Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.980
+0.050 (1.27%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Tvardi Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Debt / Equity Ratio | 0.01 | -5.43 | 0.02 | 0.01 |
| Net Debt / Equity Ratio | -1.30 | 0.19 | -0.96 | -1.07 |
| Net Debt / EBITDA Ratio | 1.21 | 0.04 | 1.21 | 2.05 |
| Net Debt / FCF Ratio | 1.60 | 0.06 | 1.07 | 2.42 |
| Quick Ratio | 3.30 | 3.05 | 6.99 | 10.23 |
| Current Ratio | 3.48 | 3.06 | 7.97 | 10.31 |
| Return on Equity (ROE) | -135.64% | -329.99% | -54.30% | - |
| Return on Assets (ROA) | -72.68% | -56.48% | -32.36% | - |
| Return on Capital Employed (ROCE) | -107.10% | -113.20% | -78.70% | -51.90% |
| Buyback Yield / Dilution | -170.52% | -0.31% | -0.09% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.